Safety of Penbraya during pregnancy
Part of Infections clinical trials.
This study monitors pregnant individuals who received the Penbraya vaccine to check for any safety concerns. It helps ensure the vaccine is safe for you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant or have been pregnant within the last year.
- You received at least one dose of Penbraya while pregnant or within 30 days before your last period.
- You agree to let your doctors share your medical information with the study team.
- You provide your contact information and your doctor's contact information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational registry that collects information about pregnant people and their babies when MenQuadfi® (a meningitis vaccine) was given during pregnancy or shortly before pregnancy. It helps researchers understand what happens to women and offspring after this vaccine exposure.
This study tests an experimental vaccine that protects against pneumococcal infections, which can cause pneumonia, meningitis, and ear infections. Your baby would get the vaccine as a series of three doses starting at about 2 months of age, followed by a booster around 12–15 months. The goal is to see how safe and how well-tolerated the vaccine is for infants.
This study tests an experimental vaccine to protect babies and toddlers from meningitis (a serious infection of the brain and spinal cord). It checks how well the vaccine works and how safe it is in young children.
This trial tests two different booster shots for meningitis B in young adults who already got the Bexsero vaccine at least 2.5 years ago. The goal is to see which booster works best to keep you protected.
This trial tests a new pneumococcal vaccine for babies around 2 months old. It aims to prevent serious infections like pneumonia and meningitis, and may offer protection against more strains than current vaccines.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
Hear when a new Meningococcal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.